Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.

Li Q, Hu J

Open source

DOI
10.1007/s10555-026-10378-3
Published
2026 Sep 10
Container
Cancer metastasis reviews
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10555-026-10378-3,
  title = {Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.},
  author = {Li Q and Hu J},
  year = {2026},
  journal = {Cancer metastasis reviews},
  doi = {10.1007/s10555-026-10378-3},
  url = {https://doi.org/10.1007/s10555-026-10378-3}
}

RIS

TY  - JOUR
TI  - Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.
AU  - Li Q
AU  - Hu J
PY  - 2026
JO  - Cancer metastasis reviews
DO  - 10.1007/s10555-026-10378-3
UR  - https://doi.org/10.1007/s10555-026-10378-3
ER  - 

APA

Q, L., & J, H. (2026). Langerhans cell histiocytosis: molecular mechanisms underlying pathogenesis and emerging targeted therapeutics.. Cancer metastasis reviews. https://doi.org/10.1007/s10555-026-10378-3

Source records